(firstQuint)CKD-391 Pharmacokinetic Study.

 To compare the CKD-391 (Experimental product) to the dose Atorvastatin calcium and Ezetimibe combination in health male subjects is the purpose of this trial.

 Following are evaluated in this trial; Characteristics and safety/Tolerability Of CKD-391.

.

 CKD-391 Pharmacokinetic Study@highlight

A randomized, open-label, 2-way crossover study to compare the pharmacokinetics and safety CKD-391 to coadministration Atorvastatin and Ezetimibe in health volunteers.

